The inaugural class will be known as Dorman Scholars, in honor of donor Paul Dorman, chairman and CEO of DFB Pharmaceuticals. Though officials refused to disclose the final amount of the donation, it is estimated to be worth $3 million, according to the report.
The medical school is scheduled to open in July 2019, pending accreditation from the Liaison Committee on Medical Education and approval from the Southern Association of Colleges and Schools Commission on College, according to the report.
“I understand the need for exceptionally trained physicians and I believe the TCU and UNTHSC School of Medicine team is creating the right formula to prepare students to practice medicine in the future,” Mr. Dorman told the Star-Telegram. “This school will change the medical and economic landscape of our community and I can’t wait to meet the students who will make up the first class.”
More articles on hospital-physician relationships:
Quotes from the Front Line: ‘I wanted to teach my medical student effective communication, but instead, she taught me’
6 hospital-physician issue stories making the rounds this week: April 10-14
Sen. Schumer pushes for accreditation of Pennsylvania medical school’s NY campus
